Andrew J. Last - 29 Apr 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, Chief Operating Officer
Signature: /s/ Andrew J. Last
Issuer symbol: BIO
Transactions as of: 29 Apr 2024
Net transactions value: -$98,928
Form type: 4
Filing time: 30 Apr 2024, 17:53:07 UTC
Previous filing: 12 Mar 2024
Next filing: 03 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO BIOB	Bio-Rad A Common Stock	Options Exercise	$0	+1,000	+20%	$0.000000	6,077	29 Apr 2024	Direct	F1, F2
transaction	BIO BIOB	Bio-Rad A Common Stock	Tax liability	$98,928	-357	-5.9%	$277.11	5,720	29 Apr 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO BIOB	Restricted Stock Units	Options Exercise	$0	-1,000	-100%	$0.000000^*	0	29 Apr 2024	Bio-Rad A Common Stock	1,000	$0.000000	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Includes 9.7660 and 27.5220 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2023 and 03/31/2024, respectively.
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.